Skip to main content

Peer Review reports

From: Efficacy and safety of scopolamine compared to placebo in individuals with bipolar disorder who are experiencing a depressive episode (SCOPE-BD): study protocol for a randomised double-blind placebo-controlled trial

Original Submission
11 Feb 2022 Submitted Original manuscript
2 Mar 2022 Reviewed Reviewer Report - Kirsty Loudon
30 Mar 2022 Author responded Author comments - Cerena Miravalles
Resubmission - Version 2
30 Mar 2022 Submitted Manuscript version 2
Publishing
2 Apr 2022 Editorially accepted
23 Apr 2022 Article published 10.1186/s13063-022-06270-4

You can find further information about peer review here.

Back to article page

Trials

ISSN: 1745-6215